API
ELV icon

Advisor Partners II’s Elevance Health ELV Stock Holding History

Advisor Partners II’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.54M Buy
12,716
+455
+4% +$206K 0.22% 75
2023
Q2 		$5.45M Buy
12,261
+659
+6% +$304K 0.26% 69
2023
Q1 		$5.33M Buy
11,602
+481
+4% +$229K 0.29% 66
2022
Q4 		$5.7M Buy
11,121
+1,394
+14% +$708K 0.35% 52
2022
Q3 		$4.42M Buy
+9,727
New +$4.65M 0.33% 54

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisor Partners II's ELV Position: Q3 2023 in Review

Advisor Partners II increased its Elevance Health (ELV) stake by 3.7% in Q3 2023, buying an estimated $206K and bringing the position to 12,716 shares worth $5.54M. The position accounts for 0.22% of the portfolio, ranked #75.

Advisor Partners II first reported a position in ELV in Q3 2022 and has held it in 5 quarters since. The position peaked at $5.7M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Advisor Partners II held 12,716 shares of Elevance Health worth $5.54M as of Q3 2023.
  • Advisor Partners II bought 455 Elevance Health shares in Q3 2023, an estimated $206K.
  • Elevance Health made up 0.22% of Advisor Partners II's portfolio in Q3 2023, its #75 holding.
  • Advisor Partners II first reported a position in Elevance Health in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Elevance Health position peaked at $5.7M in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.